DZ2892A1 - Delivery of atomized active agent by flow resistance modulation. - Google Patents

Delivery of atomized active agent by flow resistance modulation.

Info

Publication number
DZ2892A1
DZ2892A1 DZ990192A DZ990192A DZ2892A1 DZ 2892 A1 DZ2892 A1 DZ 2892A1 DZ 990192 A DZ990192 A DZ 990192A DZ 990192 A DZ990192 A DZ 990192A DZ 2892 A1 DZ2892 A1 DZ 2892A1
Authority
DZ
Algeria
Prior art keywords
delivery
active agent
flow resistance
resistance modulation
atomized active
Prior art date
Application number
DZ990192A
Other languages
French (fr)
Inventor
Andrew Clark
Original Assignee
Inhale Therapeutic Syst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic Syst filed Critical Inhale Therapeutic Syst
Application granted granted Critical
Publication of DZ2892A1 publication Critical patent/DZ2892A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DZ990192A 1998-09-14 1999-09-13 Delivery of atomized active agent by flow resistance modulation. DZ2892A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14

Publications (1)

Publication Number Publication Date
DZ2892A1 true DZ2892A1 (en) 2003-12-15

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990192A DZ2892A1 (en) 1998-09-14 1999-09-13 Delivery of atomized active agent by flow resistance modulation.

Country Status (44)

Country Link
EP (1) EP1117442A1 (en)
JP (1) JP2002524535A (en)
KR (1) KR20010075063A (en)
CN (1) CN1317977A (en)
AP (1) AP1374A (en)
AR (1) AR022090A1 (en)
AU (1) AU753014B2 (en)
BG (1) BG105430A (en)
BR (1) BR9913722A (en)
CA (1) CA2343920A1 (en)
CO (1) CO5130023A1 (en)
CZ (1) CZ2001829A3 (en)
DZ (1) DZ2892A1 (en)
EA (1) EA003476B1 (en)
EE (1) EE200100151A (en)
GE (1) GEP20043257B (en)
GT (1) GT199900156A (en)
HK (1) HK1042231A1 (en)
HN (1) HN1999000159A (en)
HR (1) HRP20010189A2 (en)
HU (1) HUP0103837A3 (en)
ID (1) ID28845A (en)
IL (2) IL141562A0 (en)
IS (1) IS5878A (en)
LT (1) LT4897B (en)
LV (1) LV12658B (en)
MA (1) MA25590A1 (en)
MY (1) MY129282A (en)
NO (1) NO20011251L (en)
NZ (1) NZ510168A (en)
OA (1) OA11781A (en)
PA (1) PA8481901A1 (en)
PE (1) PE20001061A1 (en)
PL (1) PL195574B1 (en)
SA (1) SA99200718B1 (en)
SK (1) SK3442001A3 (en)
TN (1) TNSN99173A1 (en)
TR (1) TR200101182T2 (en)
TW (1) TWI226248B (en)
UA (1) UA76085C2 (en)
UY (1) UY25711A1 (en)
WO (1) WO2000015262A1 (en)
YU (1) YU24201A (en)
ZA (1) ZA200101995B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4874483B2 (en) 1999-06-09 2012-02-15 ロバート イー. シーバース Supercritical fluid assisted nebulization and bubble drying
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
NZ535323A (en) 2002-02-25 2008-02-29 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
WO2004004798A2 (en) * 2002-07-03 2004-01-15 The Brigham And Women's Hospital, Inc. Central airway administration for systemic delivery of therapeutics
ATE353633T1 (en) * 2002-12-19 2007-03-15 Pharmacia Corp NON-HYGROSCOPIC FORMULATION CONTAINING A HYGROSCOPIC ACTIVE INGREDIENT
DE10338403A1 (en) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulation containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1 H) -oxoquinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, process for its preparation and its use as inhalant
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
AU2005237523A1 (en) * 2004-04-23 2005-11-10 Cydex Pharmaceuticals, Inc. DPI formulation containing sulfoalkyl ether cyclodextrin
UA95903C2 (en) 2005-02-24 2011-09-26 Дифьюжен Фармасьютикалз Ллк Trans carotenoids, their synthesis, formulation and uses
CN101171023A (en) * 2005-03-09 2008-04-30 小野药品工业株式会社 Particle and preparation containing the particle
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
WO2007050075A1 (en) 2005-10-26 2007-05-03 Cydex, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20100269819A1 (en) * 2006-08-14 2010-10-28 Sievers Robert E Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions
WO2008050847A1 (en) * 2006-10-25 2008-05-02 Dainippon Sumitomo Pharma Co., Ltd. Granular preparation prevented from caking
EP1925295A1 (en) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stable powder formulation containing a new antichinolinergic agent
JP2010524855A (en) 2007-04-13 2010-07-22 ディフュージョン・ファーマシューティカルズ・エルエルシー Use of bipolar trans carotenoids as and in the pretreatment of peripheral vascular disease
CN101878040A (en) 2007-10-31 2010-11-03 扩散药品有限公司 A new class of therapeutics that enhance small molecule diffusion
WO2010135495A2 (en) * 2009-05-20 2010-11-25 Aeras Global Tb Vaccine Foundation Stable, spray dried, immunogenic, viral compositions
CN108464976A (en) 2009-06-22 2018-08-31 扩散药品有限公司 Diffusion promotes compound and its independent or application together with Thrombolytic Drugs
EP2575487B1 (en) 2010-06-02 2017-10-18 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
NZ630040A (en) 2012-05-03 2016-10-28 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
WO2014074797A1 (en) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
US20180043585A9 (en) * 2013-09-20 2018-02-15 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
WO2016067252A1 (en) 2014-10-31 2016-05-06 Glaxosmithkline Intellectual Property Development Limited Powder formulation
CN115089569A (en) 2016-03-24 2022-09-23 扩散药品有限公司 Use of bipolar trans carotenoids in conjunction with chemotherapy and radiation therapy for the treatment of cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
ES2177544T3 (en) * 1992-06-12 2002-12-16 Teijin Ltd ULTRAFININE POWDER TO INHALATE AND METHOD FOR PREPARATION.
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
ATE287257T1 (en) * 1997-01-16 2005-02-15 Massachusetts Inst Technology PREPARATION OF PARTICLE-CONTAINING MEDICINAL PRODUCTS FOR INHALATION
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
PL195574B1 (en) 2007-10-31
BR9913722A (en) 2001-05-29
WO2000015262A1 (en) 2000-03-23
LT2001021A (en) 2001-11-26
KR20010075063A (en) 2001-08-09
CN1317977A (en) 2001-10-17
CZ2001829A3 (en) 2001-09-12
HRP20010189A2 (en) 2005-04-30
UY25711A1 (en) 1999-11-17
MA25590A1 (en) 2002-12-31
AU6039799A (en) 2000-04-03
YU24201A (en) 2003-08-29
JP2002524535A (en) 2002-08-06
LV12658B (en) 2001-09-20
EA003476B1 (en) 2003-06-26
HUP0103837A3 (en) 2002-11-28
AP1374A (en) 2005-02-28
EP1117442A1 (en) 2001-07-25
PA8481901A1 (en) 2002-04-25
NO20011251D0 (en) 2001-03-13
SK3442001A3 (en) 2001-11-06
GEP20043257B (en) 2004-06-25
AU753014B2 (en) 2002-10-03
EE200100151A (en) 2002-06-17
AP2001002093A0 (en) 2001-03-31
IL141562A0 (en) 2002-03-10
TNSN99173A1 (en) 2005-11-10
HUP0103837A2 (en) 2002-05-29
IL141562A (en) 2007-07-24
UA76085C2 (en) 2006-07-17
AR022090A1 (en) 2002-09-04
MY129282A (en) 2007-03-30
CO5130023A1 (en) 2002-02-27
LT4897B (en) 2002-02-25
CA2343920A1 (en) 2000-03-23
SA99200718B1 (en) 2006-11-04
PL346768A1 (en) 2002-02-25
IS5878A (en) 2001-03-05
EA200100300A1 (en) 2001-10-22
TR200101182T2 (en) 2001-09-21
BG105430A (en) 2001-12-29
GT199900156A (en) 2001-03-07
PE20001061A1 (en) 2000-10-08
HK1042231A1 (en) 2002-08-09
ZA200101995B (en) 2002-03-11
OA11781A (en) 2005-07-26
NO20011251L (en) 2001-04-17
TWI226248B (en) 2005-01-11
HN1999000159A (en) 1999-11-11
ID28845A (en) 2001-07-05
NZ510168A (en) 2003-09-26
LV12658A (en) 2001-05-20

Similar Documents

Publication Publication Date Title
DZ2906A1 (en) Delivery of atomized active agent by flow resistance modulation.
DZ2892A1 (en) Delivery of atomized active agent by flow resistance modulation.
BR0104326B1 (en) "aqueous coating composition".
ES2155124T3 (en) PHARMACEUTICAL COMPOSITIONS LIQUID BASED ON THYROID HORMONES.
ID22349A (en) DEGREE FROM 8-AZABISIKLO [3.2.1] OKTANA-, 8-AZABISIKLO [3.2.1] OKT-6-ENA-, 9-AZABISIKLO- [3.3.1] NONANA-, 9-AZA-3-OKSABISIKLO [3.3. 1] NONANA- AND 9-AZA-3-TIOBISIKLO [3.3.1] NONANA, IT'S MAKING AND USE AS AN INSECTICIDE
LT2000095A (en) Aerosolised active agent delivery
BR9804500B1 (en) amide derivative, said pharmaceutical composition and therapeutic agent.
DK1062217T3 (en) Herbicide active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
DE69928260D1 (en) SULFUR-SUBSTITUTED SULFONYLAMINOCARBOXYLIC ACID N-ARYLAMIDES, THEIR PREPARATION, THEIR USE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ITMI981774A0 (en) PHARMACEUTICAL COMPOSITIONS WITH ANALGESIC ACTIVITY
DE69821977D1 (en) LIQUID, INSECTICIDE FORMULATION FORMULATION
ITMI20001848A0 (en) DRUGS FOR INCONTINENCE.
HK1035641A1 (en) Bacteriocide compositions for agricultural and horticultural use.
IT1307264B1 (en) INSECTICIDE COMPOSITIONS.
AU1389702A (en) Optically active 2,5-bisaryl-delta<sup>1</sup>-pyrrolines and their use as pest control agents
DE69504824D1 (en) SUBSTITUTED 5,6-DIHYDRO-5-OXO-1,4-DITHIINO- (2,3-D) PYRIDAZINE DICARBONITRILES, THE COMPOSITIONS THEREOF, AND THEIR USE AS AN ANTIMICROBIAL AGENT
IT1314209B1 (en) FERTILIZING COMPOSITION PARTICULARLY SUITABLE FOR AGRICULTURAL AND BIOLOGICAL
DE69301716D1 (en) 3-azabicyclo (3.1.0) hexan-2-one derivatives, and herbicidal compositions containing these as herbicide active ingredients
FR2782243B1 (en) PREPARATION OF A SOLID PHYTOSANITARY COMPOSITION BY ATOMIZATION IN THE PRESENCE OF AN ANTI-FOAM AGENT
ES1042364Y (en) "PERFECTED DIAPER".
DK1029452T3 (en) Trailed agricultural field sprayer
UA43435C2 (en) COMPOSITION OF INGREDIENTS FOR Bitter Tincture "OLD"
IT1298987B1 (en) THERAPEUTIC COMPOSITIONS WITH ANTI-VIRAL ACTIVITIES INCLUDING YOHIMBINA AND / OR ITS SALTS AS AN ACTIVE INGREDIENT
ZA99866B (en) 2-(pyrazolyloxy)pyridin-3-ylacetic acid derivatives, compositions comprising them and their use for controlling harmful fungi and animal pests.
ES1039390Y (en) DELIMITING SYSTEM OF LANDSCAPED AREAS.